United States · FDA National Drug Code directory
ATOVAQUONE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0904-7459_9c1dfc30-52ac-4fec-a728-135917f39c1a
- Product NDC
- 0904-7459
- Form
- SUSPENSION
- Composition / generic term
- Atovaquone Oral Suspension
- Labeler
- Major Pharmaceuticals
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20240708
- Source listing expiry
- 20261231
Source-listed ingredients
- ATOVAQUONE — 750 mg/5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 3 TRAY in 1 CASE (0904-7459-25) / 6 CUP, UNIT-DOSE in 1 TRAY / 5 mL in 1 CUP, UNIT-DOSE (0904-7459-41) · 0904-7459-25
- 7 TRAY in 1 CASE (0904-7459-53) / 6 CUP, UNIT-DOSE in 1 TRAY / 5 mL in 1 CUP, UNIT-DOSE (0904-7459-41) · 0904-7459-53
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →